Giant left ventricular rhabdomyoma treated successfully with everolimus: case report and review of literature

被引:24
作者
Martinez-Garcia, Alfonso [1 ]
Michel-Macias, Carolina [2 ]
Cordero-Gonzalez, Guadalupe [2 ]
Escamilla-Sanchez, Karla I. [2 ]
Aguinaga-Rios, Monica [3 ]
Coronado-Zarco, Alejandra [2 ]
Cardona-Perez, Jorge A. [2 ]
机构
[1] Inst Nacl Perinatol Isidro Espinosa Reyes, Fetal & Pediat Cardiol, Calle Montes Urales 800,Lomas Virreyes,Lomas Chap, Mexico City 11000, DF, Mexico
[2] Inst Nacl Perinatol Isidro Espinosa Reyes, Neonatal Intens Care Unit, Mexico City, DF, Mexico
[3] Inst Nacl Perinatol Isidro Espinosa Reyes, Perinatal Genet, Mexico City, DF, Mexico
关键词
Rhabdomyoma; everolimus; newborn; sirolimus; TUBEROUS SCLEROSIS COMPLEX; CARDIAC RHABDOMYOMA; REGRESSION; NEWBORN; TUMORS;
D O I
10.1017/S1047951118000598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Intracardiac rhabdomyomas can cause severe ventricular dysfunction and outflow tract obstruction. Case report: A term newborn infant with antenatal diagnosis of giant left ventricle rhabdomyoma presented with cardiac failure and duct-dependent systemic circulation after birth. She was treated successfully with everolimus, showing decrease in tumour size and improvement in left ventricular ejection fraction. Discussion: Tumour regression rate was 0.32 cm(2)/day and improved to 0.80 cm(2)/day with the use of everolimus. Herein we report a newborn with inoperable giant left ventricular cardiac rhabdomyoma and significant regression of the tumour. To our knowledge, this is the largest left ventricular rhabdomyoma reported. A review of the literature was undertaken for comparison. Conclusion: Everolimus has proven to be efficacious in size reduction of cardiac rhabdomyomas in cases when surgical resection is not possible.
引用
收藏
页码:903 / 909
页数:7
相关论文
共 25 条
[1]   Accelerated Cardiac Rhabdomyoma Regression with Everolimus in Infants with Tuberous Sclerosis Complex [J].
Aw, Fatou ;
Goyer, Isabelle ;
Raboisson, Marie-Josee ;
Boutin, Christine ;
Major, Philippe ;
Dahdah, Nagib .
PEDIATRIC CARDIOLOGY, 2017, 38 (02) :394-400
[2]  
Bornaun H, 2016, CASE REP PEDIAT, V2016
[3]   Regression of Neonatal Cardiac Rhabdomyoma in Two Months Through Low-Dose Everolimus Therapy: A Report of Three Cases [J].
Chang, Jeng-Sheng ;
Chiou, Ping-Yun ;
Yao, Shu-Hui ;
Chou, I-Ching ;
Lin, Ching-Yuang .
PEDIATRIC CARDIOLOGY, 2017, 38 (07) :1478-1484
[4]  
Choudhry S, 2015, BMJ CASE REP
[5]   Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex [J].
Colaneri, Massimo ;
Quarti, Andrea ;
Pozzi, Marco .
CARDIOLOGY IN THE YOUNG, 2016, 26 (05) :1025-1028
[6]   Everolimus: A Challenging Drug in the Treatment of Multifocal Inoperable Cardiac Rhabdomyoma [J].
Demir, Haci Ahmet ;
Ekici, Filiz ;
Erdem, Arzu Yazal ;
Emir, Suna ;
Tunc, Bahattin .
PEDIATRICS, 2012, 130 (01) :E243-E247
[7]   Regression of Symptomatic Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex in a Newborn Receiving Everolimus [J].
Dogan, Vehbi ;
Yesil, Sule ;
Kayali, Seyma ;
Beken, Serdar ;
Ozgur, Senem ;
Ertugrul, Ilker ;
Bozkurt, Ceyhun ;
Orun, Utku Arman ;
Karademir, Selmin .
JOURNAL OF TROPICAL PEDIATRICS, 2015, 61 (01) :74-77
[8]   Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants [J].
Emoto, C. ;
Fukuda, T. ;
Mizuno, T. ;
Schniedewind, B. ;
Christians, Uwe ;
Adams, D. M. ;
Vinks, A. A. .
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (08) :411-417
[9]  
Goldblum J.R., ENZINGER WEISSS SOFT
[10]   Use of mTOR Inhibitor Everolimus in Three Neonates for Treatment of Tumors Associated With Tuberous Sclerosis Complex [J].
Goyer, Isabelle ;
Dandah, Nagib ;
Major, Philippe .
PEDIATRIC NEUROLOGY, 2015, 52 (04) :450-453